Smartwatches Spot Sickness Before You Feel It: The AI Behind the Wrist Data

Smartwatches now track far more than steps or calories. They monitor skin temperature, heart rate variability, respiratory rate and blood oxygen levels. When those readings stray from a user’s personal baseline, algorithms step in. The result can be an alert that something is off, sometimes hours before symptoms appear. Yet the systems remain better at spotting deviations than naming the exact cause.

Engadget examined this balance in detail on July 4, 2026. Features that earn FDA clearance often come wrapped in marketing that suggests near-diagnostic power. Apple has shared stories of its Watch saving lives through irregular rhythm notifications. Even Health Secretary Robert F. Kennedy Jr. has called wearables a key part of his agenda. The reality is more measured. Engadget notes that while some readings prove clinically useful, many others fall short of medical-grade reliability.

Atrial fibrillation detection stands out as a success. One study tied to the Apple Watch found that irregular pulse notifications matched confirmed AFib cases 84 percent of the time. That performance matters because AFib carries a clear signature and raises stroke risk. Doctors view it as one of the few consumer-grade features they can act on with confidence. Basic sleep patterns and daily step counts also rank high on the list of trusted metrics, according to physicians quoted by The New York Times.

Other measurements invite caution. Blood pressure estimates, detailed sleep stage breakdowns and calorie counts lack the precision doctors need for decisions. VO2 max and heart-rate variability offer only rough fitness snapshots. Proprietary recovery scores from Oura or Whoop rely on black-box formulas that give limited insight to clinicians. False positives abound. A jump in resting heart rate might signal infection. It could also reflect poor sleep or a late drink. And so trends matter more than single readings.

Researchers have chased the pre-symptomatic window for years. Stanford Medicine rolled out a Fitbit-based alarm system in 2020. The algorithm watched for sustained rises in resting heart rate paired with drops in step count. In a pilot that drew more than 5,000 participants, 32 tested positive for COVID-19. Twenty-six of them showed the expected heart-rate spike. On average they walked 1,440 fewer steps each day and slept 30 minutes longer. The system flagged infections before or at symptom onset 63 percent of the time. Michael Snyder, professor of genetics at Stanford, said detecting infection signs early “would be an enormous asset to public health.” His colleague Tejaswini Mishra added that people whose data pointed to infection could be told to isolate.

More recent modeling sharpens the case. A joint study from Texas A&M University and Stanford, published in PNAS Nexus in March 2025, simulated how smartwatch alerts could curb outbreaks. The work showed devices might register physiological shifts, such as temperature increases or altered sleep, within 12 hours of infection with COVID-19 or influenza. If users isolated promptly, transmission risk could fall by nearly 50 percent. Lead researcher Martial Ndeffo-Mbah of Texas A&M stated that even before symptoms appear, those changes “can be detected by smartwatch.” The finding suggests wearables could blunt pandemics by turning personal data into collective action. TechXplore covered the modeling in June 2025.

AI now ties the disparate signals together. Companies including Google, Oura and Whoop have added AI coaches that interpret multi-sensor streams and compare them against individual norms. Apple’s Vitals app and Oura’s Symptom Radar feature scan for clusters of anomalies without labeling them as any specific illness. Google’s Gemini model powers a Health Coach that suggests next steps. These tools operate mostly behind the scenes. They nudge users toward testing or rest. They stop short of diagnosis. The American Hospital Association highlighted parallel advances in February 2025. Analyst Ellen Knapp pointed to AI symptom trackers like Ubie that ask targeted questions and map complaints on an anatomical diagram. She noted rising investor interest and listed early detection gains for heart disease, cancer, Alzheimer’s and more. Yet Knapp’s analysis focused mainly on apps and imaging rather than wrist-worn hardware. AHA.

Pediatric applications remain an open frontier. The Murdoch Children’s Research Institute launched a study in May 2026 to test AI-powered consumer wearables, including the Apple Watch, in children undergoing chemotherapy. The goal is to catch infections early in patients whose immune systems are compromised. Researcher Lane Collier observed that most tools were built on adult data and that evidence for pediatric use stays thin. The trial at Royal Children’s Hospital will assess whether continuous monitoring delivers timely warnings without adding burden. MobiHealthNews reported on the effort. MobiHealthNews.

Accuracy varies by condition. A separate smartwatch algorithm for pulmonary infection risk, tested on 87 patients and 408 healthy controls, reached 85.9 percent overall accuracy when cough sound joined heart rate, respiratory rate, oxygen saturation and temperature data. Without the audio input, accuracy dropped to 68.2 percent. Such results show how sensor fusion and machine learning improve performance. They also underscore that no single metric tells the full story.

Privacy questions linger. Edge computing that processes data on the device itself can limit exposure. Still, most AI coaches upload readings to the cloud for heavier analysis. Users must weigh convenience against the risk that sensitive patterns reach third parties. Regulatory bodies have cleared specific alerts, such as AFib notifications or sleep apnea indicators, but they require clear disclaimers that the devices do not replace professional care.

Physicians already integrate wearable trends into conversations. A patient who sees repeated yellow alerts for elevated heart rate might schedule bloodwork sooner. Another whose recovery score tanks for days could uncover an undiagnosed chronic issue. The data becomes one more data point alongside lab results and physical exams. But when users treat app recommendations as medical advice, problems arise. The Engadget analysis warns that AI summaries risk substituting for doctor visits. Nothing on the wrist yet matches a full clinical evaluation.

Future hardware will likely pack denser sensors and faster onboard processors. Multimodal models could combine heart data, movement, temperature and even voice changes to refine predictions. Studies on structural heart disease detection through single-lead ECGs from watches have shown promise, with recent American Heart Association presentations highlighting AI’s ability to spot left-ventricular dysfunction or valve issues. Yet deployment at scale demands larger, more diverse datasets to avoid bias.

So the wrist-worn sentinels keep watch. They notice when resting heart rate climbs and steps fall away. They flag nights of restless sleep or subtle temperature drifts. Algorithms trained on thousands of user profiles turn those signals into alerts. Some prove reliable enough for clinical attention. Others invite skepticism. What matters is the conversation that follows. A smartwatch does not diagnose. It simply says something changed. The rest still belongs to the user and the clinician. And that partnership, informed by better data, may be where the real progress lies.